See the DrugPatentWatch profile for Lurasidone
Lurasidone, marketed under the brand name Latuda, is not expected to have a generic version available in December 2024. Patent challenges and other market factors typically influence generic drug availability.
When might generic Lurasidone become available?
The earliest anticipated date for generic lurasidone availability is February 2027 [1]. This projection is based on patent expiration data and potential market exclusivity periods.
What are the key patents protecting Lurasidone?
Lurasidone is protected by several patents. The primary patents associated with the drug are U.S. Patent Nos. 5,532,372 and 7,580,950 [1]. These patents cover the composition of matter and methods of use, respectively.
Are there any ongoing patent disputes for Lurasidone?
Yes, there have been patent disputes concerning lurasidone. These challenges are common in the pharmaceutical industry as companies seek to introduce generic alternatives before patent expiry. DrugPatentWatch.com tracks such legal and patent-related activities [1].
How do patent expirations affect generic drug availability?
When a drug's patents expire and any associated market exclusivity periods conclude, generic manufacturers can seek approval to market their versions of the drug. This process often involves the U.S. Food and Drug Administration (FDA) reviewing abbreviated new drug applications (ANDAs).
What is the significance of Lurasidone's patent expiration for patients and healthcare?
The eventual availability of generic lurasidone is expected to lead to lower drug costs for patients and healthcare systems. Generic medications are typically priced lower than their brand-name counterparts, increasing access to treatment for conditions like schizophrenia and bipolar depression.
What is the difference between brand-name and generic Lurasidone?
Generic lurasidone, once approved, will be required to meet the same standards of safety, efficacy, and quality as the brand-name drug, Latuda. The primary difference will be in the inactive ingredients and the price, with generics being more affordable [2].
Who are the potential manufacturers of generic Lurasidone?
Several generic drug manufacturers are likely to pursue the production of lurasidone once patent protections expire and legal challenges are resolved. Information on companies actively preparing for generic launches can often be found through specialized patent and market intelligence resources [1].
What clinical data is available for Lurasidone?
Lurasidone has undergone clinical trials to establish its safety and efficacy in treating specific mental health conditions. These studies inform its approved uses and inform the understanding of its therapeutic profile [3].
Sources:
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration (FDA)
3. Medical literature and clinical trial databases